Get the Stockscreener App
1.90
1.55%
-0.03
After Hours:
1.93
0.03
+1.58%
Pepgen Inc stock is traded at $1.90, with a volume of 528.27K.
It is down -1.55% in the last 24 hours and up +11.76% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
See More
Previous Close:
$1.93
Open:
$1.95
24h Volume:
528.27K
Relative Volume:
0.61
Market Cap:
$131.42M
Revenue:
-
Net Income/Loss:
$-77.22M
P/E Ratio:
-1.0837
EPS:
-1.7533
Net Cash Flow:
$-77.27M
1W Performance:
-13.64%
1M Performance:
+11.76%
6M Performance:
-66.07%
1Y Performance:
+31.03%
1-Day Range:
$1.8803
$2.00
1-Week Range:
$1.88
$2.275
52-Week Range:
$1.01
$7.80
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
1.90 | 133.50M | 0 | -77.22M | -77.27M | -1.7533 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Initiated | Guggenheim | Buy |
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
PepGen Inc (PEPG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PepGen Inc (PEPG) Cash Flow - TradingKey
Recover Investment Losses: Levi & Korsinsky Files Class Action Against PepGen Inc. (PEPG) - The National Law Review
PepGen Inc (PEPG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PepGen Inc (PEPG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PepGen Inc (PEPG) Institutional Confidence - TradingKey
PepGen Inc (PEPG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PepGen Inc (PEPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PEPG|PepGen Inc|Price:1.930|Chg%:-0.170 - TradingKey
PepGen Inc (PEPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Why PEPG, SGMO, PHR Are Among Top Premarket Losers Today - Stocktwits
PepGen (PEPG) Edges Lower, Holding Near Key Support ZonePut Flow Alert - dars.gov.et
PepGen Inc. (PEPG) Edges Higher as Stock Holds Above Key SupportVolume Weighted Price - dars.gov.et
PepGen Inc. (PEPG) Edges Higher, Tests Resistance After Modest GainHead and Shoulders - dars.gov.et
PepGen Q1 2026 Earnings: Narrower-than-Expected Loss Drives Shares HigherDebt Analysis Report - dars.gov.et
PepGen Inc. (PEPG) Q1 2026 Earnings: Narrower-than-expected loss drives positive stock reactionEarnings Cycle Report - dars.gov.et
PEPGPepGen Inc Latest SEC Filings - Finviz
PepGen Inc. (PEPG) Q1 2026 Earnings: Narrower-Than-Expected Loss as Biotech Advances PipelineEarnings Decline Risk - dars.gov.et
PEPG LAWSUIT ALERT: Levi & Korsinsky Notifies PepGen Inc. InvestorsLead Plaintiff Deadline August 8, 2025 - The National Law Review
PepGen Inc. (PEPG) Edges Higher as Biotech Stock Tests Key ResistanceGamma Squeeze - dars.gov.et
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Stockholders to Connect - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Investors to Inquire about Securities Investigation - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Shareholders to Connect - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Price to sales forward of PepGen Inc. – NASDAQ:PEPG - TradingView
Enterprise value to revenue forward of PepGen Inc. – BOATS:PEPG - TradingView
Price to earnings forward of PepGen Inc. – BOATS:PEPG - TradingView
Price to book forward of PepGen Inc. – NASDAQ:PEPG - TradingView
Enterprise value to EBITDA forward of PepGen Inc. – BOATS:PEPG - TradingView
Enterprise value to EBIT forward of PepGen Inc. – NASDAQ:PEPG - TradingView
Class Action Lawsuit Filed: PepGen Inc. (PEPG)Join by August 8, 2025Contact Levi & Korsinsky - The National Law Review
PEPG Stockholders Have Opportunity to Lead PepGen Inc. Class Acti - The National Law Review
PEPG INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
PEPG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Did You Lose Money on PepGen Inc. (PEPG)? Levi & Korsinsky Urges Investors to Act Before August 8, 2025 - The National Law Review
Number of shareholders of PepGen Inc. – NASDAQ:PEPG - TradingView
Price to sales forward of PepGen Inc. – BOATS:PEPG - TradingView
PepGen Inc. Actuals & Estimates (NASDAQ:PEPG) - TradingView
PEPG Forecast — Price Target — Prediction for 2027 - TradingView
PepGen (PEPG) upgraded to buy: Here's what you should know - MSN
PepGen Inc. (PEPG) Edges Higher: Key Levels and Technical OutlookPercent Below MA - dars.gov.et
PepGen Inc. 8-K Filing: Annual Meeting Results, Nasdaq Listing, and Key Company Information for June 2026 - Minichart
PepGen (PEPG) loses 14.3% in 4 weeks, here's why a trend reversal may be around the corner - MSN
PepGen Shareholders Back Directors and KPMG at 2026 Meeting - TipRanks
PepGen (PEPG) director granted 34,000 options for RA Capital funds - Stock Titan
Form 4 PepGen Ltd For: 22 June By Investing.com - Investing.com South Africa
34K PepGen (PEPG) options awarded for RA Capital-managed accounts - Stock Titan
PepGen (PEPG) investors elect Class I directors and ratify KPMG as 2026 auditor - Stock Titan
PepGen (PEPG) awards director 34,000 options vesting by next meeting - Stock Titan
PepGen (PEPG) director Habib Dable receives 34,000 stock options at $1.79 - Stock Titan
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):